This post was originally published on this site
NEW YORK (Reuters) – Vaccine maker Moderna (NASDAQ:MRNA) Inc’s chief commercial officer (CCO) said on Thursday that the size of the future COVID-19 vaccine market in the United States could be in the range of $5.2 billion to $12.9 billion, depending on the price of shots and who is eligible to receive them.
Globally, the company said the size of the high-risk population that would be eligible for the shots is around 340 million people, Moderna CCO Arpa Garay said, speaking at the company’ annual reseacrh and development event.
